Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients
NCT ID: NCT04410159
Last Updated: 2020-07-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
20 participants
INTERVENTIONAL
2020-06-22
2020-07-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Findings from this study will provide new insight into the importance of gargling in the treatment and prevention of COVID-19.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19
NCT04371965
Alternative Application Methods of Pre-procedural Povidone Iodine Mouthrinse
NCT06272019
Povidone-Iodine Oral Rinse Study
NCT05239598
Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19
NCT04344236
The Effect of Oral Antiseptic Gargles on the Oral Cavity Microbiome
NCT03141554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After consent is taken, all groups will be briefed regarding the study protocol separately.
* Group A will be briefed on the correct procedures of gargling with Betadine®. The participants will be instructed to take 10ml of povidone-iodine (PVP-I), tilt their heads backward and gargle for 30 seconds, three times per day for 7 days
* Group B will be briefed on the correct technique of gargling with Listerine®. The participants will be instructed to take 20ml of essential oils, tilt their heads backward and gargle for 30 seconds, three times per day for 7 days
* Group C will be briefed on the correct technique of gargling with hydrogen peroxide. The participants will be instructed to take 10ml of hydrogen peroxide, tilt their heads backward and gargle for 30 seconds, three times per day for 7 days
* Group D will be briefed about the involvement in this study. They will be managed according to the standard protocol of the hospital with no additional intervention.
Monitoring
1. Oropharyngeal and nasopharyngeal swabs will be taken on day 4, 6 of intervention, and day 12 post-intervention. The swabs will be subjected to detection of SARS-CoV-2 by real-time reverse transcriptase-polymerase chain reaction (rt RT-PCR).
2. Patients will be given a chart for them to record their gargling practice and symptoms (if any) during the intervention period ( 7 days)
3. Clinical data collection sheet will be provided to attending clinicians. The required information includes demographic data, daily vital signs, serial absolute lymphocytic count, LDH, chest radiograph, and symptoms. Clinical monitoring will be done until day 14 of the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Gargle with povidone-iodine
2. Gargle with essential oils
3. Gargle with tap water
4. Control
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Povidone-iodine
gargle with povidone-iodine 10mL, 30 seconds, 3 times per day, 7 days
Povidone-Iodine
Gargle
Essential Oils
gargle with essential oils 20mL, 30 seconds, 3 times per day, 7 days
Essential oils
Gargle
Tap water
gargle with tap water 100 mL, 30 seconds, 3 times per day, 7 days
Tap water
Gargle
Control
This group will receive the standard treatment protocol without any additional intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Povidone-Iodine
Gargle
Essential oils
Gargle
Tap water
Gargle
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. able to understand instructions
3. Stage 1 COVID-19
4. \< 5 days of illness or diagnosis
Exclusion Criteria
2. Unable to understand instructions
3. Stage 2 \& 3 COVID-19
4. Respiratory symptoms or fever on admission
5. Abnormal chest radiograph or computed tomography (CT) findings on admission
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Kebangsaan Malaysia Medical Centre
OTHER
Universiti Sains Islam Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NURUL AZMAWATI MOHAMED
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
NURUL A MOHAMED
Role: PRINCIPAL_INVESTIGATOR
Universiti Sains Islam Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universiti Kebangsaan Malaysia Medical Centre
Bandar Tun Razak, Kuala Lumpur, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther. 2018 Jun;7(2):249-259. doi: 10.1007/s40121-018-0200-7. Epub 2018 Apr 9.
Eggers M. Infectious Disease Management and Control with Povidone Iodine. Infect Dis Ther. 2019 Dec;8(4):581-593. doi: 10.1007/s40121-019-00260-x. Epub 2019 Aug 14.
Dennison DK, Meredith GM, Shillitoe EJ, Caffesse RG. The antiviral spectrum of Listerine antiseptic. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Apr;79(4):442-8. doi: 10.1016/s1079-2104(05)80124-6.
Satomura K, Kitamura T, Kawamura T, Shimbo T, Watanabe M, Kamei M, Takano Y, Tamakoshi A; Great Cold Investigators-I. Prevention of upper respiratory tract infections by gargling: a randomized trial. Am J Prev Med. 2005 Nov;29(4):302-7. doi: 10.1016/j.amepre.2005.06.013.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USIMalaysia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.